Devil's Claw 500 mg & Ginger Tablets with Krill Oil Softgels
Devil's Claw 500 mg & Ginger Tablets with Krill Oil Softgels — Bone & joint, as a combination pack, available for private-label manufacture from 5,000 units, produced in Turkey. In the Bone & joint range, the actives below carry their amounts as the specification gives them.
| Dosage form | Combination pack |
|---|---|
| Pack | 21 tablets + 21 softgels in a combined multi-unit blister |
| Minimum order | 5,000 units |
| Manufactured in | Turkey |
| Registration | Not yet registered in Iraq — product open for exclusive registration in your name |
| Market status | Choose your market: Iraq · Gulf · EuropeIraq: the registration status is in the row above.Gulf: private label under your own brand. The Gulf pageEurope: this formulation is filled outside the EU. Details |
| Documents | Certificate of Analysis, Certificate of Origin, Certificate of Conformity, Free Sale Certificate and MSDS — available on request. |
| Products Library | Open this formulation's card (F1645) |
About this formulation
This formulation, Devil's Claw 500 mg & Ginger Tablets with Krill Oil Softgels, belongs to the Bone & joint range; it is made in Turkey for private-label brands from 5,000 units per SKU. Our production site is not yet registered in Iraq, so the product is open for registration in your name. The production time is set in our offer for this product. Declared actives include Devil's claw concentrated extract 500 mg (min. 20 mg harpagosides), Ginger concentrated extract 200 mg (min. 10 mg gingerols) and Feverfew concentrated extract 150 mg (min. 0.3 mg parthenolides).
The Bone & joint range: Most of this list is swallowed; a smaller part is rubbed on the knee. Glucosamine, chondroitin and MSM fill the sachets and effervescent tablets, while the gels, the creams and the bath additive run on menthol, camphor, arnica and devil's claw.
Related formulations
Active ingredients
- Devil's claw concentrated extract 500 mg (min. 20 mg harpagosides) per tablet
- Ginger concentrated extract 200 mg (min. 10 mg gingerols) per tablet
- Feverfew concentrated extract 150 mg (min. 0.3 mg parthenolides) per tablet
- Vitamin C 80 mg per tablet
- Vitamin E 12 mg α-TE per tablet
- Krill oil 500 mg (phospholipids 200 mg, omega-3 77.5 mg, EPA 50 mg, DHA 27.5 mg, astaxanthin 100 µg) per softgel
Combination pack of day tablets with devil's claw, ginger and feverfew extracts, vitamin C and vitamin E, and softgels with 500 mg krill oil, 21 + 21 units in a combined blister.
Market status in detail
Iraq. Our production site for this line has no Iraqi file yet. The site registration comes first; your formulation is then filed under your own licence holder and brand. How filing works in Iraq
Gulf. We offer this formulation as private label for the Gulf states: your brand, your artwork in Arabic and English. Capsule products can be made with halal gelatine, bovine gelatine or vegan shells. On request: the full ingredient list, the certificate of analysis and the free sale certificate.
Country pages: Saudi Arabia · UAE · Kuwait · Qatar · Oman · Bahrain
Europe. This formulation is filled outside the EU. For a European brand, start from the formulations made in Germany, Italy, Spain and Poland; the finder filters by country of manufacture.
Change market: Iraq · Gulf · Europe · All markets
Shipping and document legalisation for your country are calculated separately and stated in the offer.